0001209191-14-077958.txt : 20141224
0001209191-14-077958.hdr.sgml : 20141224
20141224135855
ACCESSION NUMBER: 0001209191-14-077958
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141223
FILED AS OF DATE: 20141224
DATE AS OF CHANGE: 20141224
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERLEUKIN GENETICS INC
CENTRAL INDEX KEY: 0001037649
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 943123681
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 135 BEAVER ST
CITY: WATHAM
STATE: MA
ZIP: 02452
BUSINESS PHONE: 1-781-398-0700
MAIL ADDRESS:
STREET 1: 135 BEAVER ST
CITY: WATHAM
STATE: MA
ZIP: 02452
FORMER COMPANY:
FORMER CONFORMED NAME: MEDICAL SCIENCE SYSTEMS INC
DATE OF NAME CHANGE: 19971003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bay City Capital Management V LLC
CENTRAL INDEX KEY: 0001461543
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32715
FILM NUMBER: 141309859
BUSINESS ADDRESS:
STREET 1: 750 BATTERY STREET, SUITE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-676-3830
MAIL ADDRESS:
STREET 1: 750 BATTERY STREET, SUITE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bay City Capital Fund V Co-Investment Fund, L.P.
CENTRAL INDEX KEY: 0001409813
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32715
FILM NUMBER: 141309860
BUSINESS ADDRESS:
STREET 1: 750 BATTERY STREET
STREET 2: Suite 400
CITY: San Francisco
STATE: CA
ZIP: 94111
BUSINESS PHONE: (415) 676-3830
MAIL ADDRESS:
STREET 1: 750 BATTERY STREET
STREET 2: Suite 400
CITY: San Francisco
STATE: CA
ZIP: 94111
FORMER NAME:
FORMER CONFORMED NAME: Bay City Capital Fund V Co-Investment Fund LP
DATE OF NAME CHANGE: 20070815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bay City Capital Fund V, L.P.
CENTRAL INDEX KEY: 0001401826
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32715
FILM NUMBER: 141309861
BUSINESS ADDRESS:
STREET 1: 750 Battery Street
STREET 2: Suite 400
CITY: San Francisco
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-676-3830
MAIL ADDRESS:
STREET 1: 750 Battery Street
STREET 2: Suite 400
CITY: San Francisco
STATE: CA
ZIP: 94111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BAY CITY CAPITAL LLC
CENTRAL INDEX KEY: 0001288452
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32715
FILM NUMBER: 141309862
BUSINESS ADDRESS:
STREET 1: 750 BATTERY STREET STE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415.676.3830
MAIL ADDRESS:
STREET 1: 750 BATTERY STREET STE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
FORMER NAME:
FORMER CONFORMED NAME: BAY CITY CAPITAL FUND LLC
DATE OF NAME CHANGE: 20040423
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-12-23
0
0001037649
INTERLEUKIN GENETICS INC
ILIU
0001288452
BAY CITY CAPITAL LLC
750 BATTERY STREET, SUITE 400
SAN FRANCISCO
CA
94111
0
0
1
0
0001401826
Bay City Capital Fund V, L.P.
750 BATTERY STREET, SUITE 400
SAN FRANCISCO
CA
94111
0
0
1
0
0001409813
Bay City Capital Fund V Co-Investment Fund, L.P.
750 BATTERY STREET, SUITE 400
SAN FRANCISCO
CA
94111
0
0
1
0
0001461543
Bay City Capital Management V LLC
750 BATTERY STREET, SUITE 400
SAN FRANCISCO
CA
94111
0
0
1
0
Common Stock
2014-12-23
4
P
0
25996552
0.1003
A
46184016
I
See footnotes
Common Stock
2014-12-23
4
P
0
495400
0.1003
A
880099
I
See footnotes
Common Stock Warrant (right to buy)
0.1003
2014-12-23
4
P
0
25996552
0.00
A
2014-12-23
2021-12-23
Common Stock
25996552
25996552
I
See footnotes
Common Stock Warrant (right to buy)
0.1003
2014-12-23
4
P
0
495400
0.00
A
2014-12-23
2021-12-23
Common Stock
495400
495400
I
See footnotes
Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management V LLC, a Delaware limited liability company ("Management V"), Bay City Capital Fund V, L.P., a Delaware limited partnership ("Fund V"), and Bay City Capital Fund V Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment V"), are deemed to be a "group" for the purpose of Section 13(d) under the Securities Exchange Act of 1934. Management V is the general partner of Fund V and Co-Investment V and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V. BCC, the manager of Management V, is also an advisor to Fund V and Co-Investment V and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V.
Represent securities held by Fund V, including indirect interests of Management V. Management V disclaims beneficial ownership with respect to these securities, except to the extent of its pecuniary interest therein.
Represent securities held by Co-Investment V, including indirect interests of Management V. Management V disclaims beneficial ownership with respect to these securities, except to the extent of its pecuniary interest therein.
/s/ Michael Lawhead, attorney-in-fact
2014-12-24